Zosano Pharma Corp., a clinical-stage biopharmaceutical company, has appointed Greg Kitchener as CFO.

Kitchener was previously CFO and executive vice president at specialty pharmaceutical company BioPharmX Corp.

Fremont, Calif.-based Zosano Pharma is a clinical-stage biopharmaceutical company that provides therapeutics to patients with migraines using its Adhesive Dermally-Applied Microneedle System.